This study is looking at how well two different medications, Clevidipine Injection and other standard intravenous (IV) blood pressure medicines (like nicardipine), work to lower high blood pressure in people who have had an intracerebral hemorrhage (a type of stroke caused by bleeding in the brain). Researchers want to see if Clevidipine Injection helps more people reach a stable blood pressure target within 60 minutes compared to the other IV medicines. You might be able to join if you are 18 to 99 years old, have new stroke symptoms within 12 hours, and can start one of these IV treatments within 12 hours of your symptoms starting. The study aims to enroll 1018 participants.

Study design

This is an observational study, meaning researchers will watch how patients are treated with either Clevidipine or other standard IV blood pressure medicines. It plans to include 1018 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Blood pressure will be monitored at 15 minutes after treatment begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.